Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Ramucirumab

Summary

Risk. The use of amino acids, proteins, and peptides is not considered to pose any environmental impact.

 

This summary information comes from fass.se.

Detailed information

Assessment report

Assessment report for Cyramza (ramucirumab), 17 December 2015, EMA/CHMP/69143/2016.

"No ERA was submitted."

Fass environmental information

Fass environmental information for Cyramza from Lilly (downloaded 2019-09-04).

Risk

The use of amino acids, proteins, and peptides is not considered to pose any environmental impact.

Detailed information

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.

Author: Health and Medical Care Administration, Region Stockholm